In addition, it was shown that the E-selectin antagonist mobilized myeloma and leukemia cells from the marrow into the peripheral blood gradually within 60 min following a single injection; these cancer cells persisted in the circulation for up to 24 h and reached a ~10-fold increase at 48 h post-injection [23,45]. Here, SELE is linked to leukemia.